Vanessa Llorca

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
INTRODUCTION Epilepsy causes psychiatric disorders in 20-40% of patients impacting negatively on their quality of life. Lacosamide is a new antiepileptic as adjunctive therapy in partial seizures with or without generalization. AIM We conducted a study to assess the impact of lacosamide as to the quality of life of epileptic patients. We used the HAD(More)
  • 1